Anavex Life Sciences Corp (AVXL)

[kevindenver]

Chaiken moneyflow was one of the first indicators I started using with success 30 years ago and it's still one I watch today.

Keeping a segregated biotech only portfolio is what I used to do too. I'd look at 10 new ideas for the year and then make 10 investments with generally similar amounts. Then as each hit a fail point in their story as 90% do, I'd sell, take the tax lost, and reinvest the balance into one or 2 the remaining I thought had the strongest story in that moment in time. In one of my old risk accounts from 2015 $AVXL is the sole survivor.

On the biology front, my indication to support is Lewy Body Dementia and only within the last year has my indication been put solidly on the radar if one follows new NDS-ISS guidance. Also new for this year especially for PD is the the Alpha-Synuclein Amplification Assay to validate the process and improve patient selection for trials.

https://www.lbda.org/advancing-the-science-new-research-frameworks-proposed-for-the-biology-of-dementia-with-lewy-bodies-and-or-parkinsons-disease/